Maguire Maureen G, Alexander Judith, Fine Stuart L
Department of Ophthalmology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104-3309, USA.
Ophthalmology. 2008 Sep;115(9):1468-73, 1473.e1-2. doi: 10.1016/j.ophtha.2008.02.028. Epub 2008 May 16.
To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT).
Cross-sectional descriptive study within a multicenter, randomized clinical trial.
Patients who developed CNV during CAPT follow-up.
Inclusion criteria for CAPT specified bilateral large drusen (>or=10 drusen at least 125 micro), visual acuity >or=20/40 in each eye, and age >or=50. Exclusion criteria included CNV and geographic atrophy >1 Macular Photocoagulation Study (MPS) disc area or within 500 micro of the foveal center. One eye of each person was selected randomly for low-intensity laser treatment and the contralateral eye was observed. Fluorescein angiography was performed at baseline, annually for >or=5 years, and whenever there were symptoms of CNV. Trained readers at the CAPT Photograph Reading Center assessed color stereo photographs and angiogram negatives to identify CNV.
Choroidal neovascularization was classified by type (predominantly classic CNV, minimally classic CNV, occult only CNV, or scar), location, and area. Visual acuity was measured by certified examiners. Symmetry of characteristics between eyes of bilaterally affected patients was examined.
Choroidal neovascularization developed in 282 eyes of 225 patients. At the time of detection, 192 (68%) of the lesions were occult only, 153 (54%) were subfoveal, and 157 (56%) were <or=2 MPS disc areas. Visual acuity was >or=20/40 in 123 (69%) of 179 eyes with visual acuity measured at the time of detection. Choroidal neovascularization developed in both eyes in 57 patients (25%) during CAPT follow-up. Lesions in eyes of bilaterally affected patients were no more similar to each other than affected eyes in 2 different patients.
When patients are monitored closely, many CNV lesions can be detected outside of the fovea and when they are relatively small. Early detection may lead to improved long-term visual acuity.
描述年龄相关性黄斑变性预防试验(CAPT)中观察眼和治疗眼中新生脉络膜新生血管(CNV)的特征。
在一项多中心随机临床试验中进行的横断面描述性研究。
在CAPT随访期间发生CNV的患者。
CAPT的纳入标准规定双眼有大的玻璃膜疣(至少125微米处有≥10个玻璃膜疣)、每只眼视力≥20/40且年龄≥50岁。排除标准包括CNV和地图样萎缩面积>1个黄斑光凝研究(MPS)视盘面积或在黄斑中心凹500微米范围内。为每个人的一只眼睛随机选择进行低强度激光治疗,对侧眼进行观察。在基线时、每年(持续≥5年)以及出现CNV症状时进行荧光素血管造影。CAPT照片阅读中心的经过培训的阅片者评估彩色立体照片和血管造影底片以识别CNV。
脉络膜新生血管按类型(主要为典型CNV、微小典型CNV、仅隐匿性CNV或瘢痕)、位置和面积进行分类。由经过认证的检查者测量视力。检查双侧受累患者双眼特征的对称性。
225例患者的282只眼中发生了脉络膜新生血管。在检测时,192个(68%)病变仅为隐匿性,153个(54%)位于黄斑中心凹下,157个(56%)≤2个MPS视盘面积。在检测时有视力测量的179只眼中,123只(69%)视力≥20/40。在CAPT随访期间,57例患者(25%)双眼均发生了脉络膜新生血管。双侧受累患者眼中的病变彼此之间的相似性并不高于2例不同患者的受累眼。
当对患者进行密切监测时,许多CNV病变可在黄斑中心凹外且相对较小时被检测到。早期检测可能会提高长期视力。